Tech Company Financing Transactions
Alba Therapeutics Funding Round
Alba Therapeutics, based in Baltimore, scored $10 million from Atel Ventures, Oxford Finance and Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
11/28/2006
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Proceeds Purpose
This additional source of capital will enable the company to accelerate the clinical development of AT-1001 in celiac disease and other autoimmune indications during 2007.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 International Dr. 1040
Baltimore, MD 21202
USA
Baltimore, MD 21202
USA
Phone
Website
Email Address
Overview
Alba Therapeutics is a Baltimore-based biopharmaceutical company based at the Emerging Technology Center in Canton. Alba is dedicated to commercializing disease-modifying therapeutics and drug delivery adjuvants based on the zonulin pathway.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Bruce Peacock
President
Wendy Perrow
VP - Manufacturing
Gary Musso
Browse more venture capital transactions:
Prev: 11/28/2006: Serene Medical venture capital transaction
Next: 11/28/2006: Where Are You Now venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs